In conclusion, we provided evidence that overexpression of EGFR in head and neck cancer cells results in the activation of multiple downstream signaling pathways that act simultaneously to repress the type 1 cytokine mediated amplification of tumor T cell infiltration by suppressing the production of T-cell attracting chemokines. This evidence concerns the gene EGFR and neoplasm.